Literature DB >> 810479

Inheritance of low-level resistance to penicillin, tetracycline, and chloramphenicol in Neisseria gonorrhoeae.

P F Sparling, F A Sarubbi, E Blackman.   

Abstract

The genetics of low-level resistance to penicillin and other antibiotics in a clinical isolate and a multistep laboratory mutant of Neisseria gonorrhoea was studied by transformation. Mutations at three loci affected sensitivity to penicillin. Mutation at penA resulted in an eightfold increase in resistance to penicillin without affecting response to other antimicrobial agents. Mutation at ery resulted in a two- to fourfold increase in resistance to penicillin and similar increases in resistance to many other antibiotics, dyes, and detergents. Mutation at penB resulted in a fourfold increase in resistance to penicillin and tetracycline, the phenotypic expression of which was dependent on the presence of mutation at ery. The cumulative effect of mutations at penA, ery, and penB was an approximate 128-fold increase in penicillin resistance, to a minimum inhibitory concentration of 1.0 mug/ml. Low-level resistance to tetracycline or chloramphenicol was due to similar additive effects between mutations at the nonspecific ery and penB loci and a locus specific for resistance to each drug (tet and chl, respectively). No evidence was found for penicillinases or other drug-inactivating enzymes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810479      PMCID: PMC235963          DOI: 10.1128/jb.124.2.740-749.1975

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Stepwise introduction of transformable penicillin resistance in Pneumococcus.

Authors:  T E Shockley; R D Hotchkiss
Journal:  Genetics       Date:  1970 Mar-Apr       Impact factor: 4.562

4.  Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae.

Authors:  M J Maness; P F Sparling
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

Review 5.  Antibiotic resistance in Neisseria gonorrhoeae.

Authors:  P F Sparling
Journal:  Med Clin North Am       Date:  1972-09       Impact factor: 5.456

6.  In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae.

Authors:  I Phillips; M Ridley; D Rimmer; R Lynn
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

7.  Gonococcal pharyngeal infections. Report of 110 cases.

Authors:  A Bro-Jorgensen; T Jensen
Journal:  Br J Vener Dis       Date:  1973-12

8.  Neisseria gonorrhoeae auxotyping: differentiation of clinical isolates based on growth responses on chemically defined media.

Authors:  K Carifo; B W Catlin
Journal:  Appl Microbiol       Date:  1973-09

9.  Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae.

Authors:  M J Maness; G C Foster; P F Sparling
Journal:  J Bacteriol       Date:  1974-12       Impact factor: 3.490

10.  Genetic mapping of linked antibiotic resistance loci in Neisseria gonorrhoeae.

Authors:  F A Sarubbi; E Blackman; P F Sparling
Journal:  J Bacteriol       Date:  1974-12       Impact factor: 3.490

View more
  86 in total

1.  In vitro susceptibilities of 400 Spanish isolates of Neisseria gonorrhoeae to gemifloxacin and 11 other antimicrobial agents.

Authors:  S Berrón; J A Vázquez; M J Giménez; L de la Fuente; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Penetrability of the outer membrane of Neisseria gonorrhoeae in relation to acquired resistance to penicillin and other antibiotics.

Authors:  R A Scudamore; T J Beveridge; M Goldner
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

3.  Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae.

Authors:  L F Guymon; D L Walstad; P F Sparling
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

4.  Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae.

Authors:  Wendy L Veal; Robert A Nicholas; William M Shafer
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

Review 5.  The changing pattern of antibiotic resistance of Neisseria gonorrhoeae.

Authors:  C S Easmon
Journal:  Genitourin Med       Date:  1990-04

6.  A doctor's dilemma: choices amidst change.

Authors:  P Frederick Sparling
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

Review 7.  Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species.

Authors:  J A Dillon; K H Yeung
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

8.  Role of extracellular iron in the action of the quinone antibiotic streptonigrin: mechanisms of killing and resistance of Neisseria gonorrhoeae.

Authors:  M S Cohen; Y Chai; B E Britigan; W McKenna; J Adams; T Svendsen; K Bean; D J Hassett; P F Sparling
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

9.  The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability.

Authors:  Shuqing Zhao; Deborah M Tobiason; Mei Hu; H Steven Seifert; Robert A Nicholas
Journal:  Mol Microbiol       Date:  2005-09       Impact factor: 3.501

10.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.